Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis

A prospective cohort study

Kalle Aaltonen, Arto Heinonen, Jaana Joensuu, Pinja Parmanne, Anna Karjalainen, Tuire Varjolahti-Lehtinen, Toini Uutela, Maija Puurtinen-Vilkki, Leena Arstila, Marja Blom, Tuulikki Sokka, Dan Nordström

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalSeminars in Arthritis and Rheumatism
Volume46
Issue number6
Pages (from-to)732-739
Number of pages8
ISSN0049-0172
DOIs
Publication statusPublished - Jun 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Psoriatic arthritis
  • TNF-inhibitor
  • Methotrexate
  • Cohort study
  • Drug survival
  • Treatment response
  • RHEUMATOLOGY BIOLOGICS REGISTER
  • COLLEGE-OF-RHEUMATOLOGY
  • ANKYLOSING-SPONDYLITIS
  • CLINICAL-PRACTICE
  • BRITISH SOCIETY
  • EFFICACY
  • THERAPIES
  • METAANALYSIS
  • VALIDATION
  • CRITERIA
  • 3121 Internal medicine
  • 317 Pharmacy

Cite this

Aaltonen, Kalle ; Heinonen, Arto ; Joensuu, Jaana ; Parmanne, Pinja ; Karjalainen, Anna ; Varjolahti-Lehtinen, Tuire ; Uutela, Toini ; Puurtinen-Vilkki, Maija ; Arstila, Leena ; Blom, Marja ; Sokka, Tuulikki ; Nordström, Dan. / Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis : A prospective cohort study. In: Seminars in Arthritis and Rheumatism. 2017 ; Vol. 46, No. 6. pp. 732-739.
@article{ba19d275d9844ed9b83fac153715d466,
title = "Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort study",
keywords = "Psoriatic arthritis, TNF-inhibitor, Methotrexate, Cohort study, Drug survival, Treatment response, RHEUMATOLOGY BIOLOGICS REGISTER, COLLEGE-OF-RHEUMATOLOGY, ANKYLOSING-SPONDYLITIS, CLINICAL-PRACTICE, BRITISH SOCIETY, EFFICACY, THERAPIES, METAANALYSIS, VALIDATION, CRITERIA, 3121 Internal medicine, 317 Pharmacy",
author = "Kalle Aaltonen and Arto Heinonen and Jaana Joensuu and Pinja Parmanne and Anna Karjalainen and Tuire Varjolahti-Lehtinen and Toini Uutela and Maija Puurtinen-Vilkki and Leena Arstila and Marja Blom and Tuulikki Sokka and Dan Nordstr{\"o}m",
year = "2017",
month = "6",
doi = "10.1016/j.semarthrit.2016.09.005",
language = "English",
volume = "46",
pages = "732--739",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W B SAUNDERS CO-ELSEVIER INC",
number = "6",

}

Aaltonen, K, Heinonen, A, Joensuu, J, Parmanne, P, Karjalainen, A, Varjolahti-Lehtinen, T, Uutela, T, Puurtinen-Vilkki, M, Arstila, L, Blom, M, Sokka, T & Nordström, D 2017, 'Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort study', Seminars in Arthritis and Rheumatism, vol. 46, no. 6, pp. 732-739. https://doi.org/10.1016/j.semarthrit.2016.09.005

Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis : A prospective cohort study. / Aaltonen, Kalle; Heinonen, Arto; Joensuu, Jaana; Parmanne, Pinja; Karjalainen, Anna; Varjolahti-Lehtinen, Tuire; Uutela, Toini; Puurtinen-Vilkki, Maija; Arstila, Leena; Blom, Marja; Sokka, Tuulikki; Nordström, Dan.

In: Seminars in Arthritis and Rheumatism, Vol. 46, No. 6, 06.2017, p. 732-739.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis

T2 - A prospective cohort study

AU - Aaltonen, Kalle

AU - Heinonen, Arto

AU - Joensuu, Jaana

AU - Parmanne, Pinja

AU - Karjalainen, Anna

AU - Varjolahti-Lehtinen, Tuire

AU - Uutela, Toini

AU - Puurtinen-Vilkki, Maija

AU - Arstila, Leena

AU - Blom, Marja

AU - Sokka, Tuulikki

AU - Nordström, Dan

PY - 2017/6

Y1 - 2017/6

KW - Psoriatic arthritis

KW - TNF-inhibitor

KW - Methotrexate

KW - Cohort study

KW - Drug survival

KW - Treatment response

KW - RHEUMATOLOGY BIOLOGICS REGISTER

KW - COLLEGE-OF-RHEUMATOLOGY

KW - ANKYLOSING-SPONDYLITIS

KW - CLINICAL-PRACTICE

KW - BRITISH SOCIETY

KW - EFFICACY

KW - THERAPIES

KW - METAANALYSIS

KW - VALIDATION

KW - CRITERIA

KW - 3121 Internal medicine

KW - 317 Pharmacy

U2 - 10.1016/j.semarthrit.2016.09.005

DO - 10.1016/j.semarthrit.2016.09.005

M3 - Article

VL - 46

SP - 732

EP - 739

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 6

ER -